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Although both uveal (UM) and cutaneous (CM) melano-
ma cells derive from the transformed melanocytes, their 
biology varies significantly in several aspects. Malignant 
transformation is frequently associated with alterna-
tions in cell glycosylation, in particular those concerning 
branched complex-type N-glycans. These changes occur 
principally in β1,4-N-acetylglucosaminyltransferase III 
(GnT-III) that catalyzes the synthesis of glycans with bi-
sected N-acetylglucosamine (GlcNAc) and β1,6-N-acetyl-
glucosaminyltransferase V (GnT-V) that is involved in 
forming β1,6-branched antenna in complex-type glycans. 
We searched for the reasons of a different behavior of 
CM and UM cells in the expression of GnT-III and GnT-V 
and their oligosaccharide products. Our study showed 
that UM cells have more β1,6-branched glycans than CM 
cells, what results from a higher expression of MGAT5 
gene encoding GnT-V. The higher β1,6-branching of 
glycans in UM may contribute to their higher potential 
to migrate on fibronectin and weaker binding to main 
extracellular matrix proteins, observed in our previous 
studies.
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INTRODUCTION
Complex-type N-glycans present on the cell surface 
are necessary for cellular interactions (Yoshimura et al., 
1995b; Guo et al., 2001; Zhang et al., 2004). Changes in 
the amount and composition of complex-type structures 
have been frequently observed in the transformation 
and progression of different types of tumors (Laidler 
& Lityńska, 1997; Taniguchi & Korekane, 2011), in-
cluding melanoma (Pocheć et al., 2003; Przybyło et al., 
2007; Pocheć et al., 2013). The increase in the size of 
N-glycans is the result of increased branching of com-
plex-type structures (Kim & Varki, 1997; Karaçali et al., 
2014). One of the most commonly observed changes in 
the glycosylation profile of tumor cells is an enhanced 
synthesis of the antenna linked β1,6 to the core struc-
ture of N-glycans (Dennis et al., 1987; Lityńska et al., 
2008). It has been shown that β1,6-branching is inhib-
ited when bisected N-acetylglucosamine (GlcNAc) is 
added to the complex-type structures during the previ-
ous step of oligosaccharide processing pathway (Zhao et 
al., 2006). The key factor that determines the structure 
of the complex-type N-glycans is cell-specific expression 
of Golgi glycosyltransferases (Taniguchi & Korekane, 
2011). The formation of β1,6-branching in N-glycans 
is catalyzed by β1,6-N-acetylglucosaminyltransferase 
V (GnT-V) encoded by MGAT5 gene, while bisect-
ed GlcNAc is bound to the core structure by β1,4-N-
acetylglucosaminyltransferase III (GnT-III) encoded by 
MGAT3 gene (Taniguchi et al., 1996). The expressions 
of GnT-III and GnT-V and their products are strong-
ly associated with carcinogenesis (Taniguchi et al., 1999), 
and therefore the altered expression of glycosyltranfer-
ases is extensively investigated in the human surgery re-
sected sections and in vitro models for use as prognostic 
markers in cancer diagnosis.
Although uveal (UM) and cutaneous (CM) melano-
ma cells derive from the transformed melanocytes, their 
biological properties vary significantly in several aspects 
(ten Berge et al., 1994; Jovanovic et al., 2013). The de-
velopment of UM and CM has a different genetic back-
ground; about 50% of CM have functional mutations in 
BRAF gene that activate Ras-Raf-MEK-ERK pathway, 
whereas in UM cells this mutation was not found (Bel-
mar-Lopez et al., 2008; Shtivelman et al., 2014). In turn, 
ocular melanoma cells are characterized by mutations in 
GNAQ and GNA11 genes, encoding the α-subunit of G 
protein (Nikolaou et al., 2012). UM and CM progression 
also differs remarkably; the well-defined stages of pro-
gression can be distinguished in CM in contrast to UM 
(Seftor et al., 1999; Chudnovsky et al., 2005). Additional-
ly, CM and UM melanoma cells metastasize preferentially 
to various organs, due to different ways of dissemination 
(Folberg, 1993; van den Bosch et al., 2010).
Our group has investigated the glycosylation profiles 
of melanoma cells for over fifteen years. We have clearly 
demonstrated that the glycosylation profile of adhesion 
proteins (mainly integrins) depends on the stage of tu-
mor development (Pocheć et al., 2003, Przybyło et al., 
2007; Pocheć et al., 2013) and the location of metas-
tasis (Kremser et al., 2008; Janik et al., 2010). Here we 
searched for the reasons of a different behavior of UM 
and CM cells in the surface glycosylation. The present 
study was designed to compare the expression of GnT-
III and GnT-V enzymes and their products in primary 
melanoma cells of different origin, uveal vs. cutaneous. 
The results of the previous studies have suggested that 
the increase in β1,6-branching begins in the early stage 
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of oncogenic transformation (Demetriou et al., 1995; Ito 
et al., 2001; Pocheć et al., 2015). Our study showed that 
UM cells are more abundant in β1,6-branched glycans 
than CM cells and this results from a higher expression 
of MGAT5 gene.
MATERIALS AND METHODS
Cell lines and reagents. Primary human melanoma 
cell lines, two cutaneous (FM-55-P, IGR-39) and two 
uveal (92-1, mel-202) were obtained from the ESTDAB 
(European Searchable Tumour Cell Line Database) Mel-
anoma Cell Bank (Tűbingen, Germany). RNeasy Plus 
Mini Kit (74134) and Omniscript RT Kit (205113) were 
purchased from Qiagen (Hilden, Germany). RPMI1640 
medium (72400) and fetal bovine serum (FBS, 10270) 
were procured from Life Technologies (Gibco, Paisley, 
UK). Penicillin-streptomycin solution (P4333), protease 
inhibitor cocktail (P2714), Total Protein Kit, Micro Low-
ry, Peterson’s Modification (TP0300), High Molecular 
Weight Markers (HMW, SDS6H), polyclonal rabbit an-
ti-GAPDH IgG (G9545) and alkaline phosphatase-conju-
gated goat anti-mouse IgG (A1682) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Monoclonal prima-
ry antibodies against GnT-III and GnT-V were kind-
ly provided by Prof. Naoyuki Taniguchi and Prof. Eiji 
Miyoshi (Osaka University Graduate School of Medicine, 
Osaka, Japan). Alkaline phosphatase (AP)-conjugated 
sheep anti-rabbit IgG (AP322A) was obtained from Mil-
lipore (Chemicon, Temecula, CA, USA). FITC-conjugat-
ed (fluorescein-labeled Phaseolus vulgaris erythroagglutinin, 
PHA-E, FL-1121 and fluorescein-labeled Phaseolus vulgaris 
leucoagglutinin, PHA-L, FL-1111) and biotinylated lec-
tins (PHA-E, B-1125 and PHA-L, B-1115), Carbo-Free 
blocking solution (SP-5040) and Vectashild with DAPI 
(H-1200) were provided by Vector Laboratories (Burl-
ingame, CA, USA). RIPA buffer (89900) and PageRul-
er Prestained Protein Ladder (26616) were ordered 
from Thermo Scientific (Carlsbad, CA, USA). Laemmli 
sample buffer (LSB, 161-0737) and β-mercaptoethanol 
(161-0710) were procured from Bio-Rad (Hercules, CA, 
USA). Substrates for alkaline phosphatase (AP), 5-bro-
mo,4-chloro,3-indolyphosphate (BCIP, 11383221001) 
and nitroblue tetrazolium (NBT, 11383213001) were 
from Roche (Mannheim, Germany).
Cell culture and cell lysate preparation. Melanoma 
cells were cultured in RPMI1640 with 10% FBS and an-
tibiotics (100 U/ml penicillin, 100 μg/ml streptomycin) 
at 37°C in 5% CO2 humid atmosphere (CO2 incubator, 
Lab Line Instruments). The cells were lysed in RIPA 
buffer containing protease inhibitors. The lysates were 
centrifuged (15 000 rpm) for 20 min at 4°C and the pro-
tein concentration was measured in the collected super-
natants using the Total Protein Kit (Micro Lowry, Peter-
son’s Modification) and BSA as a standard.
Real-time PCR. MGAT3 and MGAT5 expressions 
were analyzed quantitatively using real-time PCR (qRT-
PCR). RNA was extracted using RNeasy Protect Mini 
Kit and cDNA was synthesized in reverse transcription 
using the Omniscript RT Kit according to the manufac-
turer’s protocols. qRT-PCR was performed as described 
previously (Bubka et al., 2014) with minor modification. 
To assess the expression of MGAT3 and MGAT5 genes 
the values of Ct (cycle threshold) were normalized to 
the expression level of glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) used as an endogenous control 
according to the equation: 
∆Ct = Ct tested gene - Ct endogenous control
Sequence of GAPDH primers were as follows, for-
ward: 5′-CAGCCTCAAGATCATCAGCA-3′, reverse: 
5′-GTCTTCTGGGTGGCAGTGAT-3′.
Western blotting. GnT-III and GnT-V expression 
was analyzed by Western blotting. Thirty µg of total 
cell lysate protein were boiled in LSB with 5% β-mer-
captoethanol for 5 min, separated on 8% SDS/PAGE 
gel, transferred to a polyvinylidene difluoride membrane 
(PVDF), and detected using the monoclonal antibod-
ies. After overnight blocking in 1% BSA in TBST, the 
membranes were incubated for 1 h at RT with mouse 
anti-GnT-III, mouse anti-GnT-V and rabbit anti-GAP-
DH antibodies diluted 1:100 (anti-GnT-III, anti-GnT-V) 
or 1:4000 (anti-GAPDH) in 1% BSA in TBST. Then, 
AP-conjugated goat anti-mouse IgG was applied in a 
1:4000 dilution, followed by incubation at RT for 1 h. 
Tested enzymes and GAPDH as an endogenous control 
were visualized by colorimetric reaction using BCIP and 
NBT substrates for AP. HMW protein markers were 
used to calculate the relative molecular weights of GnT-
III and GnT-V. Band intensities were measured densi-
tometrically in relation to GAPDH in UVImap analysis 
software (UVItec, Cambridge, UK).
Lectin blotting. The expression of complex-type 
N-glycans with bisecting GlcNAc and β1,6-branched was 
detected using biotinylated PHA-E and PHA-L lectins, 
respectively. Protein extracts (10 µg) were SDS/PAGE 
separated on 8% gels and electroblotted. The PVDF 
membranes were blocked with Carbo-Free blocking 
solution in TBS (50 mM Tris/HCl, pH 7.5, 150 mM 
NaCl) overnight at 4°C to prevent non-specific bind-
ing of lectins. Then, the membranes were probed with 
PHA-E and PHA-L lectins (1:4000, in TBS containing 1 
mM MgCl2, 1 mM CaCl2 and 1 mM MnCl2) for 1 h at 
RT followed by incubation with streptavidin-conjugated 
AP (1:4000, in TBS) for 1 h at RT. Glycans-bound lec-
tins were detected by AP colorimetric reaction.
Fluorescent staining. The cells were cultured on 
coverslips placed in 4-well plates overnight. Before stain-
ing, the cells were washed three times with PBS, fixed in 
2% paraformaldehyde for 10 min at RT and incubated 
with FITC-conjugated PHA-E and PHA-L lectins (di-
luted 1:100 in 2% BSA in PBS) overnight at RT. The 
excess of lectins was removed by washing with PBS, the 
slides were mounted with Vectashield with DAPI and 
the coverslips were sealed. Images were captured in a 
Zeiss confocal microscope (LSM 510) and analyzed in 
LSM Image Browser (Carl Zeiss MicroImaging GmbH, 
Germany).
Statistical analysis. The results are represented as 
means of three measurement ± standard deviation (S.D.). 
Duncan test was used to determine statistical significance 
(*p < 0.05) between samples of melanoma cells.
RESULTS
The expression of GnT-V is higher in UM
The expression of GnT-III and GnT-V was analyzed 
on gene and protein levels. To determine MGAT3 and 
MGAT5 expression, RNA isolated from melanoma cells 
was subjected to real-time PCR and the relative abun-
dance of transcripts was assessed using GAPDH as a 
reference gene. Our data showed that both 92-1 and 
mel-202 UM cells expressed more transcript for GnT-V 
than FM-55-P and IGR-39 CM cells. The level of 
MGAT3 transcript was lower than MGAT5 in all ana-
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lyzed cell lines, but we did not observe any differences 
related to the origin of melanomas (Fig. 1).
Immunoblot analysis of GnT-III and GnT-V expres-
sion on protein level showed a difference related to mel-
anoma origin in the case of the second enzyme. The 
higher content of GnT-V protein in 92-1 and mel-202 
UM cell lines (Fig. 2B) resulted probably from a high-
er transcription of MGAT5 gene. We observed three 
isoforms of GnT-III enzyme with different molecular 
weights, 92, 76 and 70 kDa. The significantly highest ex-
pression of two 92 and 76 kDa GnT-III isoforms was 
noticed in IGR-39 cutaneous cells. The study did not 
reveal any relationship between GnT-III expression and 
the location of melanoma origin (Fig. 2A).
GlcNAc β1,6-branched N-glycans are more abundant in 
UM
PHA-E and PHA-L lectins specifically recognizing 
structures with bisecting GlcNAc and β1,6-branched 
complex-type glycans, respectively, were used to detect 
these products of GnT-III and GnT-V catalytic activi-
ties. We have applied two methods for the detection 
of signals from glycoprotein-bound lectins, AP-based 
colorimetric reaction in lectin blotting and fluorescence 
detection in confocal microscopy. Lectin blotting stud-
ies showed that PHA-E was bound to bisecting Glc-
NAc bearing glycoproteins ranging from 40 to 200 kDa, 
while PHA-L staining of β1,6-branched glycoproteins 
was observed within the whole range of used molecular 
weight standards. PHA-E-binding glycoprotein pattern 
was similar for both CM cell lines, while the intensity 
of PHA-E staining differed within tested UM cells and 
the glycoprotein pattern recognized by this lectin varied 
significantly between UM and CM cells (Fig. 3A). What 
is interesting, 92-1 cells showed the highest expression 
of N-glycans with bisecting GlcNAc (Fig. 3A) and the 
highest expression of MGAT3 among all cells tested 
(Fig. 1), but not the expression of GnT-III at protein 
level (Fig. 2A). The amount of β1,6-branched N-gly-
cans was proportionally higher in UM cells than in CM 
cells (Fig. 3B) and it was consistent with the higher ex-
pression of MGAT5 gene (Fig. 1) and GnT-V protein 
(Fig. 2B). Lectin fluorescence in confocal microscopy 
studies confirmed the differences in glycan expression 
levels obtained in lectin blotting (Fig. 4).
DISCUSSION
Many previous studies have shown that glycosylation 
affects intracellular interactions and contact with ECM 
proteins (Gu et al., 2012; Christiansen et al., 2014) via 
regulation of signaling pathways (Zhao et al., 2008). 
Differences in the glycan structure may contribute to 
functional dissimilarity of melanoma cells from eye and 
skin despite both types of melanomas develop from 
the same type of cells. Our previous study, performed 
on the same set of uveal and cutaneous melanoma cell 
lines, demonstrated different adhesion and migration 
abilities of UM and CM cells. Cutaneous cells bound 
strongly to FN (Przybyło et al., 2008), vitronectin (Janik 
et al., 2014), collagen (COL) and laminin (LN) (Laidler 
et al., 2006), but migrated poorly on FN (Przybyło et 
al., 2008) in comparison to uveal cells. Swainsonine 
Figure 1. The expression of MGAT5 gene is higher in uveal (92-
1, mel-202) than cutaneous (FM-55-P, IGR-39) melanoma cells. 
The isolated RNA was reverse transcribed and subjected to re-
al-time PCR. The expression of MGAT3 and MGAT5 genes was nor-
malized to the expression leśvel of GAPDH according to the equa-
tion: ∆Ct = Ct tested gene - Ct endogenous control. A high Ct value corresponds 
to low gene expression. *indicates p < 0.05. CM, cutaneous melano-
ma; UM, uveal melanoma.
Figure 2. The amount of GnT-III (A) and GnT-V (B) enzymes detected in cutaneous (FM-55-P, IGR-39) and uveal (92-1, mel-202) mela-
noma cells. 
Protein extracts (30 µg) were SDS/PAGE separated on 8% gel in reducing conditions, electroblotted and probed with monoclonal anti-
bodies against GnT-III and GnT-V. After incubation with AP-conjugated anti-mouse IgG, the bands corresponding to GnT-III and GnT-V 
enzymes were visualized by colorimetric reaction and the intensity of bands was measured densitometrically. CM, cutaneous melanoma; 
UM, uveal melanoma; HMW, High Molecular Weight Markers (Sigma-Aldrich, SDS6H).
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that reduces formation of complex-type glycans, includ-
ing β1,6-branched ones, affected more efficiently uveal 
than cutaneous cell migration on FN (Przybyło et al., 
2008). We assume that even though surface glycans are 
not the only one, they are an important element influ-
encing the differences in cell migration on FN. Here 
we present the characterization of com-
plex-type N-glycans β1,6-branched and 
with bisecting GlcNAc in melanoma cells 
derived from primary tumors of ocular and 
cutaneous origins. Our analysis showed a 
significantly higher expression of GnT-V 
enzyme (Figs. 1, 2B) and its products 
(Figs. 3B, 4B) in UM in comparison to 
CM. GnT-V is an enzyme that is the most 
strongly associated with cancer progression 
and metastasis of other glycosyltransferas-
es involved in creation of multi-antennary 
N-glycans (Miyoshi et al., 2012). Results 
of many previous studies showed that the 
amount of β1,6-branched glycans increases 
with progression of various cancers (Tani-
guchi et al., 1999) and promotes metastasis 
(Couldrey & Green, 2000). Immunohisto-
chemical analysis of over hundred human 
colorectal cancer cases surgically resect-
ed showed that the expression of GnT-V 
correlated with metastasis of this cancer 
(Murata et al., 2000). Also other immuno-
histochemical studies performed on clinical 
samples collected postoperatively provided 
the evidence for positive correlation be-
tween GnT-V level and metastatic poten-
tial of gastric cancers (Tian et al., 2008; 
Huang et al., 2014), endometrial cancer 
(Yamamoto et al., 2007) and mucinous 
ovarian cancers (Takahashi et al., 2009). 
On the other hand, there is a group of 
cancers that shows a favorable prognosis 
when the expression of GnT-V is higher. 
This inversely proportional relationship was observed 
in tissue sections of oral squamous cell carcinoma (Seto 
et al., 2013), neuroblastoma (Inamori et al., 2006), blad-
der cancers (Ishimura et al., 2006), non-small cell lung 
cancers (Dosaka-Akita et al., 2004) and testicular germ 
Figure 3. Glycosylation profiles of complex-type N-glycans with bisecting Glc-
NAc (A) and β1,6-branched (B) in cutaneous (FM-55-P, IGR-39) and uveal (92-
1, mel-202) melanoma cells. 
Protein extracts (10 µg) were SDS/PAGE separated on 8% gel in reducing con-
ditions, electroblotted and probed with biotinylated PHA-E for bisecting GlcNAc 
bearing glycans (A) and PHA-L for β1,6-branched glycans (B). After incubation 
with streptavidin-conjugated AP, glycosylation profiles were visualized by colori-
metric reaction. Densitometric signal from all glycoproteins recognized by the lec-
tin in each cell line was measured and the values are given below in the frame. CM, 
cutaneous melanoma; UM, uveal melanoma
Figure 4. Surface expression of β1,6-branched complex-type N-glycans is higher in uveal melanoma (UM) than in cutaneous mela-
noma (CM). 
Cells growing on coverslips were fixed in 2% paraformaldehyde, incubated with FITC-conjugated PHA-E for detection of bisecting GlcNAc 
bearing glycans (A) and FITC-conjugated PHA-L for detection of β1,6-branched glycans (B) and lectin staining (green) was visualized in a 
Zeiss LSM 510 META confocal microscope. DAPI was used to stain cell nuclei (blue). Scale bar — 100 mm
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cell tumors (Kyan et al., 2008). In view of above data, 
using GnT-V expression level as a prognostic marker 
seems to be promising, but cancer-specific. To the best 
of our knowledge, GnT-V expression was not analyzed 
in clinical section of melanoma tumors, but it has been 
studied on in vitro models. Positive correlation between 
the expression of GnT-V and its products vs. melano-
ma progression was shown in our previous studies for 
cell lines derived from vertical growth phase and met-
astatic lesion of the same patients (Pocheć et al., 2013). 
Here we proved that the expression of GnT-V and its 
products at the early stage of melanoma progression is 
also dependant on the origin of melanoma.
Our present study did not show any correlation 
between the expression of GnT-III (Fig. 1, 2A) and 
N-glycans with bisecting GlcNAc (Fig. 3A, 4A) with 
respect to the place of melanoma origin. The ex-
pression of GnT-III was demonstrated frequently in 
chemically induced tumors in animal models (Nara-
simhan et al., 1988) and in cancer cell lines (Bubka 
et al., 2014). But the number of clinical data on the 
relationship between GnT-III and cancer progression 
is much lower than those describing GnT-V expres-
sion in cancers. The elevated level of GnT-III was 
observed in sera of patients with hepatomas and liver 
cirrhosis (Ishibashi et al., 1989), while the activity of 
GnT-III was increased in patients with two hemato-
logical cancers, myelogenous leukemia and multiple 
myeloma (Yoshimura et al., 1995a). Based on the stud-
ies on animal and cell line models it is known that 
GnT-III and its products have a suppressive effect on 
tumor progression (Isaji et al., 2010). The transfection 
of cDNA encoding GnT-III to highly metastatic sub-
clone of B16-F1 murine melanoma cell line exhibited 
a higher expression of GnT-V products resulted in the 
reduced invasion into Matrigel and weakened adhesion 
to COL and LN. The injection of GnT-III-transfected 
melanoma cells into nude mice suppressed lung me-
tastasis (Yoshimura et al., 1995b). The ability to re-
duce cancer by GnT-III was confirmed in several fur-
ther studies on different models, among them through 
intracellular pathways induced by epidermal growth 
factor receptor excessively modified by overexpressed 
GnT-III (Gu et al., 2009). In our study, the glycosyla-
tion pattern obtained for bisecting GlcNAc glycans 
was quite different from β1,6-branching (Fig. 3), indi-
cating that different proteins are substrates for GnT-
III and GnT-V and/or the proteins are modified by 
these enzymes with various intensity. What is import-
ant, both CM cells displayed the higher expression of 
bisecting GlcNAc than β1,6-branched glycans though 
the reaction with PHA-E was observed in a less nar-
row range of molecular weight markers than PHA-L 
(Fig. 3). Taking into account suppressive properties 
of GnT-III action, the higher expression of bisected 
GlcNAc on CM glycoproteins may contribute to their 
lower ability to migrate on FN and stronger binding 
to ECM proteins than in case of UM cells showed in 
our previous studies (Laidler et al., 2006; Przybyło et 
al., 2008; Janik et al., 2014).
Determining glycosylation pattern and searching for 
features specific for melanoma cells of different origins 
is a crucial stage in understanding biology of melano-
ma and a reason for differences in the development and 
progression of UM and CM. The higher level of GnT-V 
and β1,6-branched glycans in UM than CM cells may be 
one of the reasons for lower adhesion and higher migra-
tion exhibited by UM cells.
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